Treos Bio Company
Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.
Headquarters:
London, England, United Kingdom
Last Funding Type:
Convertible Note
Investors Number:
4
Last Funding Date:
2021-03-31
Employee Number:
1-10
Total Funding:
38363455
Founded Date:
2013-01-01
Estimated Revenue:
$1M to $10M
Industry:
Peptides and Proteins
Funding Status:
Early Stage Venture